DuPont, OligoCo to Develop Oligonucleotide Synthesizer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DuPont and OligoCo today announced a deal for the development of a next-generation oligonucleotide synthesizer.

Under the deal, DuPont business Pioneer Hi-Bred will work with OligoCo to develop the platform. Pioneer will combine the new technology with its proprietary gene shuffling technology and other synthetic biology tools to improve the throughput and rate of success in early discovery research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.